Hipopara-Red, Real Life Experience in 322 Patients With Hypoparathyroidism
- PMID: 33409439
- PMCID: PMC7774093
- DOI: 10.1210/jendso/bvaa181
Hipopara-Red, Real Life Experience in 322 Patients With Hypoparathyroidism
Abstract
Context: Hypoparathyroidism is a rare disease and, as such, its natural history, long-term complications, and correct clinical management remain unclear.
Objective: To describe the natural history and clinical characteristics of the disease.
Design and setting: To present a retrospective observational analysis from 7 specialized centers in Buenos Aires, Argentina.
Patients: Chronic hypoparathyroid patients followed-up between 1985 and December 2018.
Main outcome measures: Data on demographics, etiology, clinical complications, biochemical parameters, dual-energy x-ray absorptiometry (DXA) values, and treatment doses were collected.
Results: A total of 322 subjects with chronic hypoparathyroidism were included; 85.7% were female, the mean age was 55.2 ± 16.8 years, and the mean age at diagnosis was 43.8 ± 16.8 years. Prevalence of surgical hypoparathyroidism was 90.7%, with the most common causes being thyroid carcinoma and benign thyroid disease. A history of hypocalcemia requiring hospitalization was present in 25.7% of the whole group and in 4.3% of patients who had a history of seizures. Overall, 40.9% of our patients had reported at least 1 neuromuscular symptom. Renal insufficiency was present in 22.4% of our patients and was significantly associated with age (P < 0.0001). Hyperphosphatemia was present in 42% of patients. A history of severe hypocalcemia, paresthesias, tetany, ganglia calcifications, seizures, and cataracts was significantly higher in nonsurgical patients.
Conclusion: Although these patients were followed-up by experienced physicians, clinical management was heterogeneous and probably insufficient to assess all the potential complications of this chronic disease. Almost 70% of the study's group of patients met the experts' indications for considering the use of rhPTH 1-84. Being aware of this fact is the 1st step in improving our medical management of this disease in the future.
Keywords: PTH; hyperphosphatemia; hypocalcemia; hypoparathyroidism.
© The Author(s) 2020. Published by Oxford University Press on behalf of the Endocrine Society.
Figures
References
-
- Gafni RI, Collins MT. Hypoparathyroidism. N Engl J Med. 2019;380(18):1738–1747. - PubMed
-
- Brandi ML, Bilezikian JP, Shoback D, et al. Management of hypoparathyroidism: summary statement and guidelines. J Clin Endocrinol Metab. 2016;101(6):2273–2283. - PubMed
-
- Underbjerg L, Sikjaer T, Mosekilde L, Rejnmark L. Cardiovascular and renal complications to postsurgical hypoparathyroidism: a Danish nationwide controlled historic follow-up study. J Bone Miner Res. 2013;28(11):2277–2285. - PubMed
-
- Underbjerg L, Sikjaer T, Mosekilde L, Rejnmark L. The epidemiology of nonsurgical hypoparathyroidism in denmark: a nationwide case finding study. J Bone Miner Res. 2015;30(9):1738–1744. - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous